Standout Papers

Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disea... 2014 2026 2018 2022 333
  1. Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease (2014)
    Larysa Fedchuk, Fabio Nascimbeni et al. Alimentary Pharmacology & Therapeutics

Immediate Impact

4 from Science/Nature 63 standout
Sub-graph 1 of 21

Citing Papers

Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
2024 Standout
Acquisition of epithelial plasticity in human chronic liver disease
2024 StandoutNature
1 intermediate paper

Works of Larysa Fedchuk being referenced

Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease
2014 Standout

Author Peers

Author Last Decade Papers Cites
Larysa Fedchuk 588 339 78 213 10 632
Archana Bhatt 622 314 50 284 16 716
Kimberly Ramirez 534 395 39 115 6 557
S. Al‐Sam 426 187 103 181 7 523
L. Bonyhay 599 343 85 227 9 664
Hamed Aryafar 478 355 21 99 15 576
A. Djibre 414 135 93 275 8 534
Jin Hwa Kang 487 171 102 283 9 622
Dae Yoon Kim 403 273 33 79 15 535
V. Cartier 479 417 35 82 12 641
Joanie Salotti 647 253 70 365 6 684

All Works

Loading papers...

Rankless by CCL
2026